These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12108550)

  • 21. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
    Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
    Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial synergy of cysteine and aspartic protease inhibitors.
    Semenov A; Olson JE; Rosenthal PJ
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2254-8. PubMed ID: 9736544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.
    Pandey KC; Wang SX; Sijwali PS; Lau AL; McKerrow JH; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9138-43. PubMed ID: 15964982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.
    Sijwali PS; Shenai BR; Gut J; Singh A; Rosenthal PJ
    Biochem J; 2001 Dec; 360(Pt 2):481-9. PubMed ID: 11716777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins.
    Xie SC; Dogovski C; Hanssen E; Chiu F; Yang T; Crespo MP; Stafford C; Batinovic S; Teguh S; Charman S; Klonis N; Tilley L
    J Cell Sci; 2016 Jan; 129(2):406-16. PubMed ID: 26675237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum.
    Sijwali PS; Koo J; Singh N; Rosenthal PJ
    Mol Biochem Parasitol; 2006 Nov; 150(1):96-106. PubMed ID: 16890302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites.
    Gamboa de Domínguez ND; Rosenthal PJ
    Blood; 1996 May; 87(10):4448-54. PubMed ID: 8639807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
    Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
    Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
    Rosenthal PJ; Lee GK; Smith RE
    J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
    Li X; Chen H; Jeong JJ; Chishti AH
    Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.
    Pandey KC; Singh N; Arastu-Kapur S; Bogyo M; Rosenthal PJ
    PLoS Pathog; 2006 Nov; 2(11):e117. PubMed ID: 17083274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport.
    Singh A; Rosenthal PJ
    J Biol Chem; 2004 Aug; 279(34):35236-41. PubMed ID: 15192087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
    Teixeira C; Gomes JR; Gomes P
    Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteases of malaria parasites: new targets for chemotherapy.
    Rosenthal PJ
    Emerg Infect Dis; 1998; 4(1):49-57. PubMed ID: 9452398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine proteases of malaria parasites: targets for chemotherapy.
    Rosenthal PJ; Sijwali PS; Singh A; Shenai BR
    Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible effect of cysteine protease inhibitors on the release of malaria parasites from infected erythrocytes.
    Glushakova S; Mazar J; Hohmann-Marriott MF; Hama E; Zimmerberg J
    Cell Microbiol; 2009 Jan; 11(1):95-105. PubMed ID: 19016793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
    Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
    Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
    Naughton JA; Nasizadeh S; Bell A
    Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones.
    Shenai BR; Lee BJ; Alvarez-Hernandez A; Chong PY; Emal CD; Neitz RJ; Roush WR; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Jan; 47(1):154-60. PubMed ID: 12499184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.